Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04095208
Title Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study (CONGRATS)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonié
Indications

sarcoma

Therapies

Nivolumab + Relatlimab

Nivolumab

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.